Abstract:Background:Bone marrow-derived mesenchymal stem cells (MSCs) have been proved in vitro to inducible differentiate into many kinds of cells of mesenchymal tissues such as osteocytes,chondrocytes, adipocytes,myocytes et al,especially myocardium cells. Recently it was shown that the wall thickness and heart function were improved after MSCs implantation in animal experiments and large-scale clinical trials. But other studies didn’t show that grafted stem cells can bring benefits to heart function in patients with cardiac disease. These therapeutic differences may be rise at least because of lack of visible method to trace in vivo grafted stem cells bio-behaviors such as survive,proliferation,distribution and differentiation. In recent decade an in vivo cellular tracking techniques by using luciferase marker so called BLU have been developed for long-term study of stem cells homing and migration. Bioluminescent imaging ( BLU) technology is a technology to integrate exogenous report luciferase genes into host cells,and express luciferase. This enzyme will give out the visible light when it reacts with its substrate fluorescein under the condition of existing O2 and ATP,to track living cells in real time. In BLU technology the vector for gene transfection is considered a principal because it very closely links to gene transfection efficiency and hence cells lumination. Objective:By using reconstructed-lentivirus vector transfection and bioluminescent imaging techniques to monitor in vivo survival and proliferation and migration of grafted human mesenchymal stem cells (hMSCs) in mice. Methods:Firefly-Luciferase (LUC) -Lentivirus vector were constructed and co-cultured with hMSCs in vitro. Then transfected hMSCs were subcutaneously injected into mice. Either in vitro and in vivo biophotonic imaging of hMSCs were detected by using Xenogen Visible System. Results:1. When multiplicity of infection (MOI) was 100,transfection efficiency of LUC-lentivirus vector could come to (29. 6 ±1. 5)%. Transfected- hMSCs had expressed LUC after 20 successive generation. Indicating this reconstructed lentivirus-LUC-vector has the characteristics of high transfection sensitivity to hMSCs,and high stability for exogenous reporter gene integration and its expression. 2. No morphological and proliferation effect on hMSCs were observed after co- culture with constructed lentivirus vector for 20 generation. This demonstrating that neither lentivirus vector nor exogenous reporter gene has cytotoxicity to targeting cells. 3. Detected in vivo bioluminescence intensity was positively correlated with grafted mass of transfected-LUC hMSCs ( R2 = 0. 9826 ). 4. Since cellular transplantation,in vivo bioluminescence signal bounded injection location were detectable and the signal intensity were linear faded out until to 6th day. Means the survival,homing,proliferation and migration of Firefly-Luciferase gene transfected hMSCs can be quantitatively in vivo monitored in real time. Conclusion: Reconstructed descytotoxicityly lentivirus vector is an effective and safety tool for Firefly-Luciferase gene integrating into hMSCs. Thus by using bioluminescent tracer techniques the phenotype and potential involving homing,proliferation and migration of LUC-transfectied hMSCs can be quantitatively in vivo real-timely monitored.

Observation of bone marrow-derived mesenchymal stem cells targeting glioma with in vivo bioluminescence imaging

Migration and localization of bone marrow mesenchymal stem cells labeled by DAPI in the brain of glioma rat models

[Study of Bone Mesenchymal Stem Cells Tropism for Hepatic Tumors and Effect on the Form of Tumor Stromal].

In Vivo Tracking of Systemically Administered Allogeneic Bone Marrow Mesenchymal Stem Cells in Normal Rats through Bioluminescence Imaging

Bone marrow stromal stem cell tropism for malignant glioma

DIFFERENTIATION OF BONE MESENCHYMAL STEM CELLS TO NEURAL CELLS AND MIGRATION IN THE ADULT RAT BRAIN WITH GLIOMA

In vivo monitoring of luciferase labeled bone marrow mesenchymal stem cells by bioluminescent in rats

Migration to Gliomas of Bone Mesenchymal Stem Cells Transfected with Cytosine Deaminase Gene Following Transplantation in Vivo

In Vivo Tracking of the Tropism of Mesenchymal Stem Cells to Malignant Gliomas Using Reporter Gene-Based MR Imaging

bone marrow derived mesenchymal stem cells mediated dual gene therapy for glioblastoma

In Vivo Tracing of Transplanted Bone Marrow Mesenchymal Stem Cells with Bioluminescence Imaging

Monitoring the Migration of Bone Marrow Derived Mesenchymal Stem Cells to Intracranial Glioma by Sodium Iodide Sympoter

In Vivo Tracking of Superparamagnetic Iron Oxide Nanoparticle-Labeled Mesenchymal Stem Cell Tropism to Malignant Gliomas Using Magnetic Resonance Imaging. Laboratory Investigation.

The Experimental Study on Tropism of Magnetic Labeled Bone Marrow Mesenchymal Stem Cells for Hepatocellular Carcinoma

Transplantation of Hypoxia Preconditioned Bone Marrow Mesenchymal Stem Cells Enhances Angiogenesis and Neurogenesis after Cerebral Ischemia in Rats.

Quantification of the Engraftment Status of Mesenchymal Stem Cells in Glioma Using Dual-Modality Magnetic Resonance Imaging and Bioluminescence Imaging

The biological characteristics of stem cells transplanted into glioma models

In Vivo Monitoring of Hmscs Stem Cell by Bioluminescent Tracer in Mice

Imaging of Human Mesenchymal Stromal Cells: Homing to Human Brain Tumors

Molecular Imaging for Comparison of Different Growth Factors on Bone Marrow-Derived Mesenchymal Stromal Cells’ Survival and ProliferationIn Vivo

Bone Marrow Stromal Cell Versus Neural Stem Cell Transplantation in A C6 Glioma Rat Model